Vera Adema

13PUBLICATIONS
85CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsHaematological tumoursGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 06, 2026
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic Approaches.

|Apr 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes.

Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar

|Nov 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial.

Juan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien

|Mar 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes.

Juan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma

|Feb 08, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.

Natthakan Thongon, Feiyang Ma, Natalia Baran

|Oct 09, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromes.

Vera Adema, Irene Ganan-Gomez, Feiyang Ma

Pageof 3

Frequent Collaborators

9 joint publications

Guillermo Garcia-Manero

8 joint publications

Simona Colla

7 joint publications

Feiyang Ma

7 joint publications

Rashmi Kanagal-Shamanna